|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Impairment of intangible asset and capitalized development | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest and other income | |||||
| Interest and other expense | |||||
| Interest and other income, net | |||||
| Loss from operations before income taxes | |||||
| Income tax provision | |||||
| Net loss attributable to common stockholders | |||||
| Unrealized gain on investments | |||||
| Comprehensive loss | |||||
| Net loss per share attributable to common stockholders, basic (in dollars per share) | |||||
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | |||||
| Weighted-average shares used in computing net loss per share attributable to common shareholders, basic (in shares) | |||||
| Weighted-average shares used in computing net loss per share attributable to common shareholders, diluted (in shares) | |||||
Loading...